Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Accounts Payables: 2009-2012

Historic Accounts Payables for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $4.3 million.

  • Lexicon Pharmaceuticals' Accounts Payables fell 22.08% to $4.3 million in Q3 2012 from the same period last year, while for Sep 2012 it was $4.3 million, marking a year-over-year decrease of 22.08%. This contributed to the annual value of $6.0 million for FY2011, which is 91.26% up from last year.
  • As of Q3 2012, Lexicon Pharmaceuticals' Accounts Payables stood at $4.3 million, which was down 5.96% from $4.6 million recorded in Q2 2012.
  • Over the past 5 years, Lexicon Pharmaceuticals' Accounts Payables peaked at $6.0 million during Q4 2011, and registered a low of $3.1 million during Q1 2009.
  • Moreover, its 3-year median value for Accounts Payables was $4.6 million (2012), whereas its average is $4.5 million.
  • In the last 5 years, Lexicon Pharmaceuticals' Accounts Payables plummeted by 46.63% in 2010 and then spiked by 91.26% in 2011.
  • Lexicon Pharmaceuticals' Accounts Payables (Quarterly) stood at $5.9 million in 2009, then plummeted by 46.63% to $3.2 million in 2010, then surged by 91.26% to $6.0 million in 2011, then dropped by 22.08% to $4.3 million in 2012.
  • Its Accounts Payables stands at $4.3 million for Q3 2012, versus $4.6 million for Q2 2012 and $5.3 million for Q1 2012.